Health Care / Hospitals
Releases published in the last 30 days. 
Page 3 of 3
- Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
- 6/8/2026 10:37:39 AM
- Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector • Sarclisa administered via the CirCLIQ ® OBI offers a treatment experience designed around the needs of patients and HCPs and enables flexible administration in either home or outpatient settings • Sarclisa is the first anticancer treatment to …
- « Previous
- 1
- 2
- 3
- Next »